International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-1 doi: 10.5281/zenodo.10517390
Original Article
Serum Calcium and Serum Magnesium Levels in Newly Detected Hypertensive Patients
 ,
 ,
Published
Jan. 16, 2024
Abstract

Background: Hypertension is a complex cardiovascular disorder with multifactorial etiology. This study aimed to investigate the association between serum calcium and magnesium levels and hypertension.

Methods: A prospective observational study was conducted with 100 newly diagnosed hypertensive patients and 100 normotensive controls. Serum calcium and magnesium levels were measured, and their correlation with blood pressure was analyzed.

Results: Hypertensive patients exhibited significantly higher serum calcium levels (9.8 ± 0.6 mg/dL) compared to normotensive controls (9.4 ± 0.5 mg/dL, p < 0.001). Conversely, serum magnesium levels were lower in hypertensive patients (1.9 ± 0.2 mg/dL) than in controls (2.1 ± 0.2 mg/dL, p = 0.003). A positive correlation was found between serum calcium levels and blood pressure severity (systolic: r = 0.28, p = 0.004; diastolic: r = 0.19, p = 0.03), while an inverse correlation was observed for magnesium (systolic: r = -0.31, p = 0.002; diastolic: r = -0.25, p = 0.01).

Conclusion: The study highlights the significant association of serum calcium and magnesium levels with hypertension. These findings suggest the potential of serum mineral levels as predictive markers and therapeutic targets in hypertension management.

Recommended Articles
Loading Image...
Volume-5, Issue-1
Citations
836 Views
46 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved